Breadcrumb Home IMPAACT News IMPAACT News News March 2026 Announcements Call for Applications: Early Career Investigator Program 2026-2028 Cycle February 2026 Announcements IMPAACT at CROI 2026 December 2025 Announcements 2025 Year in Review: A Message from Our Network Chairs Search Enter a search term. Filter Topics AllAnnouncementsMeetingsSpotlight SeriesStudy Results Date All20262025202420232022202120202019201820162014 Sort Date AscDate Desc Submit Search Showing 70 news items. March 2022 Announcements IMPAACT 2017 (MOCHA) Data Informs U.S. FDA Approval of Cabenuva for HIV Treatment in Virologically Suppressed Adolescents March 2022 Announcements IMPAACT 2014 Informs U.S. FDA’s Approval for Use of Doravirine in Pifeltro® and Delstrigo® Among Children November 2021 Announcements IMPAACT Investigator Identifies COVID-19 Omicron Variant November 2021 Announcements IMPAACT Remembers Carol Onyango September 2021 Announcements IMPAACT P1108 Informs WHO TB Management Recommendation May 2021 Announcements IMPAACT MOP Updated April 2021 Announcements HANC Webinar Announcement March 2021 Announcements Recent Updates to DAIDS Policies, Procedures, and Guidance Documents March 2021 Announcements European Commission Grants EMA Approval for Dolutegravir Dispersible Tablets For the Treatment of Children Living with HIV in Europe March 2021 Announcements IMPAACT 2010 Primary Results Released Pagination Previous page Prev Page 1 Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Next page Next
March 2022 Announcements IMPAACT 2017 (MOCHA) Data Informs U.S. FDA Approval of Cabenuva for HIV Treatment in Virologically Suppressed Adolescents
March 2022 Announcements IMPAACT 2014 Informs U.S. FDA’s Approval for Use of Doravirine in Pifeltro® and Delstrigo® Among Children
March 2021 Announcements European Commission Grants EMA Approval for Dolutegravir Dispersible Tablets For the Treatment of Children Living with HIV in Europe
